ADVERTISEMENT

GlaxoSmithKline Pharma Names Bhushan Akshikar As New Managing Director

Akshikar replaces Sridhar Venkatesh, who is moving to a new senior role within GSK Group effective Dec. 1, 2022

<div class="paragraphs"><p>(Source:&nbsp;<a href="https://unsplash.com/@hansreniers?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Hans Reniers</a>/ <a href="https://unsplash.com/s/photos/pharma?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>)</p></div>
(Source: Hans Reniers/ Unsplash)

GlaxoSmithKline Pharmaceuticals on Monday said it has appointed Bhushan Akshikar as Managing Director for a period of four years effective Dec. 1, 2022.

Akshikar replaces Sridhar Venkatesh, who is moving to a new senior role within GSK Group effective Dec. 1, 2022, the drug firm said in a statement.

Akshikar joined GSK India in Sept. 2011 to lead the specialty and commercial excellence business units.

Before joining GSK, Akshikar spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care business units in local and regional positions living in India, South Korea and Belgium.